| Drug Name |
Cilazapril monohydrate |
| Drug ID |
BADD_D00465 |
| Description |
Cilazapril is an ACE inhibtor class drug used in the treatment of hypertension and heart failure. It belongs to the angiotensin-converting enzyme inhibitors (ACE inhibitors) class of drugs. It is a prodrug that is hydrolyzed after absorption to its main metabolite cilazaprilat. It is branded as Inhibace in Canada and other countries, Vascace and Dynorm in a number of European countries, among many other names. None of these varieties are available in the United States. |
| Indications and Usage |
Cilazapril is an ACE inhibtor class drug used in the treatment of hypertension and heart failure. |
| Marketing Status |
Not Available |
| ATC Code |
C09AA08 |
| DrugBank ID |
DB01340
|
| KEGG ID |
D07699
|
| MeSH ID |
D017315
|
| PubChem ID |
56329
|
| TTD Drug ID |
D04GKO
|
| NDC Product Code |
Not Available |
| Synonyms |
Cilazapril | Cilazapril Monohydrobromide | Cilazapril, Anhydrous | Cilazapril Anhydrous | Cilazapril Monohydrate | Ro 31-2848 | Ro 31 2848 | Ro 312848 | Ro-31-2848 | Ro312848 | Cilazapril Hydrate | Cilazapril, (S*)-Isomer | Inhibace |
